Pre-referral artesunate in severe malaria - Authors' reply

The Lancet

Volumn 373, Issue 9677, 2009, Pages 1763-

  Gomes, Melba ^a   Makubalo, Lindiwe ^b   Gyapong, John ^c   Faiz, Abul ^d   Warsame, Marian ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b South Africa Ministry of Health   (South Africa)

^c MINISTRY OF HEALTH   (Ghana)

^d MINISTRY OF HEALTH AND FAMILY WELFARE   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; PLACEBO;

BLOOD EXAMINATION; BRAIN DAMAGE; DEATH; DIAGNOSTIC TEST; DISEASE COURSE; HUMAN; LETTER; MALARIA; PRIORITY JOURNAL; RURAL AREA;

EID: 65649096218     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60981-8     Document Type: Letter

References (4)

1. In: Arrow K.J., Panosian C.B., and Gelband H. (Eds). Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance (2004), National Academies Press, Washington, DC
2. Bloom B.R., Gelband H., and Laxminarayan R. Consultative forum on AMFm: the affordable medicines facility-malaria. Resources for the Future (October 2008)
3. Bryce J., el Arlfeen S., Pariyo G., et al. Reducing child mortality: can public health deliver?. Lancet 362 (2003) 159-164
4. de Savigny D., Kasale H., Mbuya C., and Reid G. Fixing Health Systems (2008), IDRC, Ottawa